Pancreatic Cancer Research

ResearcherFirst Affiliated Hospital Zhejiang UniversityNo recent work listed

Wenxuan Wu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0009-0005-9627-4202; OpenAlex author ID A5017886139. Sources: OpenAlex.

Their work

Papers
3
Trials
0
Grants
0
Labs led
0
Collaborators
7
Papers, trials and grants by year

2017: 2 papers · 2018: none · 2019: none · 2020: none · 2021: 1 paper

Papers 3

  1. Serum Soluble PD-L1, PD-L2, and B7-H5 as Potential Diagnostic Biomarkers of Human Pancreatic Cancer. Co-author DOI 10.7754/clin.lab.2021.210103↗
  2. B7-H4 is a prognostic biomarker for poor survival in patients with pancreatic cancer. Co-author DOI 10.1016/j.humpath.2017.05.023↗
  3. MicroRNA Expression Profiling of Pancreatic Cancer Cell Line L3.6p1 Following B7-H4 Knockdown. Co-author DOI 10.1159/000485086↗

Closest collaborators

The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Yun Qian · 1 shared paper, 2021 · strength 0.16
  2. Hangping Yao · 2 shared papers, 2017 · strength 0.13
  3. Lingwei Shen · 2 shared papers, 2017 · strength 0.13
  4. Bo Hong · 2 shared papers, 2017 · strength 0.13
  5. Yun Qian · 2 shared papers, 2017 · strength 0.13
  6. Qi Wang · 1 shared paper, 2017 · strength 0.06
  7. Chenyu W Hu · 1 shared paper, 2017 · strength 0.06

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.